Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Priapism Management

Clinical Presentation and Diagnosis

  • The American Urological Association recommends that all patients presenting with priapism must be evaluated emergently to identify the subtype, as acute ischemic priapism represents a true urologic emergency requiring immediate intervention to prevent permanent erectile dysfunction 1, 2
  • The duration of erection is a critical threshold, with >4 hours defining priapism 3
  • Patients with sickle cell disease require concurrent urologic and hematologic management 4, 5
  • Recurrent episodes of priapism suggest stuttering (recurrent ischemic) priapism 6

Diagnostic Approach

  • Cavernous blood gas analysis is the gold standard for classification, with ischemic priapism characterized by pO₂ <30 mmHg, pCO₂ >60 mmHg, and pH <7.25 1
  • Color duplex ultrasonography can help diagnose ischemic priapism, with little to no cavernous arterial flow 1, 2
  • Complete blood count and hemoglobin electrophoresis can help evaluate for sickle cell disease 4, 5

Management Strategies

  • The American Urological Association recommends a stepwise algorithmic approach for acute ischemic priapism, starting with intracavernosal phenylephrine (100-500 mcg) 1, 2
  • Aspiration and irrigation may be combined with phenylephrine injections if initial treatment fails 1, 2
  • Surgical shunting, including distal shunts (Winter, Ebbehoj, or Al-Ghorab procedures), may be necessary if medical management fails 1, 2
  • Early penile prosthesis placement may be considered for prolonged ischemic priapism (>36-48 hours) to prevent corporal fibrosis and preserve penile length 1, 2

Special Population: Sickle Cell Disease

  • Concurrent management approach is recommended, with primary focus on urologic relief of erection using standard ischemic priapism protocols 4, 5
  • Hydration, oxygenation, analgesia, and exchange transfusion may be necessary as concurrent interventions 5
  • Urologic intervention should not be delayed for hematologic management 5

Complications of Delayed or Inadequate Treatment

  • Delayed treatment of ischemic priapism can result in time-dependent tissue damage, with minimal smooth muscle damage if treated within 12 hours, but widespread necrosis and permanent erectile dysfunction if treatment is delayed beyond 24-48 hours 1
  • Long-term sequelae of ischemic priapism include erectile dysfunction, penile fibrosis, and shortening 1, 2

Critical Clinical Pitfalls and How to Avoid Them

  • Delaying urologist involvement can result in poor outcomes, and early urologist consultation is essential when a patient presents to the emergency department 1, 2
  • Misclassifying priapism type can lead to unnecessary interventions, and cavernous blood gas analysis should always be obtained before treatment 1
  • Using the wrong sympathomimetic agent, such as epinephrine or norepinephrine, can cause significant cardiovascular side effects, and phenylephrine is the recommended agent 1